Docetaxel-containing chemotherapy protocols appear to increase the risk of hospitalisation for early and late adverse events in women with early-stage operable breast cancer. A retrospective cohort study from the Cancer Institute NSW comprising 3,950 women between 2008 and 2012 found almost a third of women (30.6%) required emergency hospitalisation within six months of initiating chemotherapy. ...
Already a member?
Enter your email to keep reading.